Correlation Between Phio Pharmaceuticals and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Seres Therapeutics, you can compare the effects of market volatilities on Phio Pharmaceuticals and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Seres Therapeutics.
Diversification Opportunities for Phio Pharmaceuticals and Seres Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Phio and Seres is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Seres Therapeutics
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Seres Therapeutics. In addition to that, Phio Pharmaceuticals is 1.04 times more volatile than Seres Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 474.00 in Seres Therapeutics on August 27, 2024 and sell it today you would lose (397.00) from holding Seres Therapeutics or give up 83.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Seres Therapeutics
Performance |
Timeline |
Phio Pharmaceuticals Corp |
Seres Therapeutics |
Phio Pharmaceuticals and Seres Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Phio Pharmaceuticals and Seres Therapeutics
The main advantage of trading using opposite Phio Pharmaceuticals and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Valuation Check real value of public entities based on technical and fundamental data |